Suchergebnisse - "Zibellini, Silvia"

PubPharm (66)

21

A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders

enthalten in: British journal of haematology | 2019

von Varettoni, M. | Zibellini, S. | Boveri, E. | +15

CommentIn: Br J Haematol. 2019 Nov;187(4):413-415. - PMID 31298748

22

Ruxolitinib treatment and risk of B-cell lymphomas in myeloproliferative neoplasms

enthalten in: American journal of hematology | 2019

von Rumi, E. | Zibellini, S. | Boveri, E. | +11

23

JAK inhibitors and risk of B-cell lymphomas

enthalten in: Blood | 2019

von Rumi, E. | Zibellini, S.

CommentOn: Blood. 2019 May 23;133(21):2348-2351. - PMID 30796023

24

Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein : A multicentric study of the Rete Ematologica Lombarda (REL) network

enthalten in: American Journal of Hematology | 2019

von Varettoni, M. | Boveri, E. | Zibellini, S. | +20

25

Ruxolitinib treatment and risk of B‐cell lymphomas in myeloproliferative neoplasms

enthalten in: American Journal of Hematology | 2019

von Rumi, E. | Zibellini, S. | Boveri, E. | +11

26

A risk‐stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders

enthalten in: British Journal of Haematology | 2019

von Varettoni, M. | Zibellini, S. | Boveri, E. | +15

27

Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance

enthalten in: Haematologica | 2017

von Varettoni, M. | Zibellini, S. | Defrancesco, I. | +10

28

Clinical significance of somatic mutation in unexplained blood cytopenia

enthalten in: Blood | 2017

von Malcovati, L. | Gallì, A. | Travaglino, E. | +18

CommentIn: Blood. 2017 Jun 22;129(25):3282-3283. - PMID 28642360

29

Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2016

von Della Porta, M. | Gallì, A. | Bacigalupo, A. | +34

30

Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia

enthalten in: Blood | 2016

von Elena, C. | Gallì, A. | Such, E. | +20

CommentIn: Blood. 2016 Sep 8;128(10):1318-9. - PMID 27609540